| Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy K Krug, EJ Jaehnig, S Satpathy, L Blumenberg, A Karpova, M Anurag, ... Cell 183 (5), 1436-1456. e31, 2020 | 313 | 2020 |
| Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer EA Bowling*, JH Wang*, F Gong, W Wu, NJ Neill, IS Kim, S Tyagi, ... Cell 184 (2), 384-403. e21, 2021 | 111 | 2021 |
| Trisomy of a Down syndrome critical region globally amplifies transcription via HMGN1 overexpression CT Mowery, JM Reyes, L Cabal-Hierro, KJ Higby, KL Karlin, JH Wang, ... Cell reports 25 (7), 1898-1911. e5, 2018 | 56 | 2018 |
| Reduction of global H3K27me3 enhances HER2/ErbB2 targeted therapy A Hirukawa, S Singh, J Wang, JP Rennhack, M Swiatnicki, ... Cell Reports 29 (2), 249-257. e8, 2019 | 35 | 2019 |
| Radiomic biomarkers of tumor immune biology and immunotherapy response JH Wang, KA Wahid, LV van Dijk, K Farahani, RF Thompson, CD Fuller Clinical and Translational Radiation Oncology 28, 97-115, 2021 | 33 | 2021 |
| Intensity standardization methods in magnetic resonance imaging of head and neck cancer KA Wahid, R He, BA McDonald, BM Anderson, T Salzillo, S Mulder, ... Physics and imaging in radiation oncology 20, 88-93, 2021 | 18 | 2021 |
| Advances in imaging for HPV-related oropharyngeal cancer: applications to radiation oncology TC Salzillo, N Taku, KA Wahid, BA McDonald, J Wang, LV van Dijk, ... Seminars in radiation oncology 31 (4), 371-388, 2021 | 17 | 2021 |
| DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells R Ramabadran, JH Wang, JM Reyes, AG Guzman, S Gupta, C Rosas, ... Nature cell biology 25 (4), 528-539, 2023 | 10 | 2023 |
| Loss of de novo DNA methyltransferase DNMT3A impacts alternative splicing in hematopoietic stem cells R Ramabadran, J Wang, A Guzman, SM Cullen, L Brunetti, M Gundry, ... Blood 130, 1, 2017 | 7 | 2017 |
| Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction A Koire, YW Kim, J Wang, P Katsonis, H Jin, O Lichtarge Plos one 12 (3), e0174766, 2017 | 3 | 2017 |
| PSMA-targeted therapy for non-prostate cancers JH Wang, AP Kiess Frontiers in Oncology 13, 2023 | 2 | 2023 |
| Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation JH Wang, V Salama, L McCoy, C Dede, T Ajayi, A Moreno, ... Radiotherapy and Oncology 180, 109465, 2023 | 1 | 2023 |
| Introduction to Clinical Trials and Drug Development for Radionuclide Therapies N Lin, JH Wang, AY Jia, AP Kiess Radiotheranostics-A Primer for Medical Physicists I, 96-105, 2024 | | 2024 |
| Pathway Mutations are Associated with Clinical Outcomes in Localized Pancreatic Cancer Treated with Neoadjuvant Chemoradiation Followed by Surgery J Wang, T Lin, AV Reddy, C Hill, S Sehgal, T McPhaul, JM Herman, J He, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e348-e349, 2023 | | 2023 |
| Early introduction to clinical radiation oncology through a self-directed competency-based medical student curriculum. C Claunch, S Dalwadi, J Wang, MS Ludwig Journal of Clinical Oncology 41 (16_suppl), 11038-11038, 2023 | | 2023 |
